Chordate Medical Holding AB (CMH) - Total Liabilities
Based on the latest financial reports, Chordate Medical Holding AB (CMH) has total liabilities worth Skr4.14 Million SEK (≈ $445.82K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Chordate Medical Holding AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Chordate Medical Holding AB - Total Liabilities Trend (2015–2024)
This chart illustrates how Chordate Medical Holding AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Chordate Medical Holding AB asset portfolio.
Chordate Medical Holding AB Competitors by Total Liabilities
The table below lists competitors of Chordate Medical Holding AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
STRATA Skin Sciences Inc
NASDAQ:SSKN
|
USA | $27.61 Million |
|
t42 IoT Tracking Solutions PLC
LSE:TRAC
|
UK | GBX6.75 Million |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
USA | $7.42 Million |
|
FAT Brands Inc
NASDAQ:FATBW
|
USA | $1.79 Billion |
|
Physiomics Plc
LSE:PYC
|
UK | GBX165.00K |
|
Anemoi International Ltd
LSE:AMOI
|
UK | GBX220.87K |
|
Litigation Capital Management Limited
LSE:LIT
|
UK | GBX424.87 Million |
|
WICKET GAMING AB
F:7Q4
|
Germany | €35.31 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Chordate Medical Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Chordate Medical Holding AB's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chordate Medical Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chordate Medical Holding AB (2015–2024)
The table below shows the annual total liabilities of Chordate Medical Holding AB from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr8.34 Million ≈ $897.00K |
+21.35% |
| 2023-12-31 | Skr6.87 Million ≈ $739.21K |
-9.24% |
| 2022-12-31 | Skr7.57 Million ≈ $814.43K |
+48.07% |
| 2021-12-31 | Skr5.11 Million ≈ $550.03K |
-8.33% |
| 2020-12-31 | Skr5.58 Million ≈ $600.04K |
-29.17% |
| 2019-12-31 | Skr7.87 Million ≈ $847.21K |
-20.14% |
| 2018-12-31 | Skr9.86 Million ≈ $1.06 Million |
-9.68% |
| 2017-12-31 | Skr10.91 Million ≈ $1.17 Million |
-5.73% |
| 2016-12-31 | Skr11.58 Million ≈ $1.25 Million |
-2.60% |
| 2015-12-31 | Skr11.89 Million ≈ $1.28 Million |
-- |
About Chordate Medical Holding AB
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.